Precision medicine for MDS, what drugs for which patients?
Transforming the care of patients with precision medicine
The impact of new drugs and the changing role of transplants in multiple myeloma
Current projects at City of Hope: CAR T-cells, vaccines and a novel nuceloside analogue
KEYNOTE-183 trial of pembrolizumab in multiple myeloma: trial design and rationale